Should adults with suspected acute bacterial meningitis get adjunctive corticosteroids?

James C. Pile, MD
Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation

David L. Longworth, MD
Deputy Chairman, Department of Medicine, Tufts University School of Medicine, Boston, MA

Address: James C. Pile, MD, Section of Hospital Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail pilej@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

James C. Pile, MD
Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation

David L. Longworth, MD
Deputy Chairman, Department of Medicine, Tufts University School of Medicine, Boston, MA

Address: James C. Pile, MD, Section of Hospital Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail pilej@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

James C. Pile, MD
Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation

David L. Longworth, MD
Deputy Chairman, Department of Medicine, Tufts University School of Medicine, Boston, MA

Address: James C. Pile, MD, Section of Hospital Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail pilej@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.